Protocol modifications: Start lower doses (BPC-157 200mcg vs 500mcg, GHK-Cu 1mg vs 3mg) with slower titration, simplify regimens (once daily vs multiple doses), prioritize evidence-based options (Cerebrolysin for glaucoma over speculative peptides), involve family members in administration and monitoring, focus on most impactful intervention if resources limited
Restore and protect your skin barrier with natural, bio-identical ingredients
doi.org/10.1056/NEJMoa2032183 2Lincoff A.M., et al
Detoxification Support : Morning intake aligns with the body's natural detoxification processes, helping to flush out toxins accumulated overnight
Kiara DeWitt, our founder and a BSN, RN, CPN with a background in neurosurgery and pediatric nursing at Cook Childrens Hospital, built InjectCo around a simple belief: that patients deserve a clinical environment where they feel heard and where treatment decisions are made on evidence, not revenue targets